BridgeMD
New treatment option for Breast Cancer Survivors
Official title The Effect of Myofascial Chain Release Techniques on Shoulder Joint Range of Motion in Breast Cancer Survivors
ClinicalTrials.gov ID: NCT05386628
What this study is testing
- What it's testing
- In breast cancer patients, limitation of shoulder joint movement occurs following mastectomy surgery. Studies have reported that damage to the fascia on the pectoralis major muscle during mastectomy surgery contributes to the development of the limitation.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 30 to 60, women only
You may be able to join if
- Women between the ages of 30-60
- Having breast surgery within 2 years
- Not have received conservative treatment for shoulder rehabilitation in the last 6 months
- Having limitation of movement of the shoulder joint due to breast surgery
You likely can't join if
- Not having agreed to participate in the study
- Having undergone radical mastectomy surgery
- Having connective tissue disease
- Presence of brachial plexus paresis/plegia
- Presence of radiogenic fibrosis
- Presence of additional orthopedic (scoliosis, etc.), neurological (multiple sclerosis, stroke, etc.) and rheumatological diseases (ankylosing...
See the full eligibility criteria
- Women between the ages of 30-60
- Having breast surgery within 2 years
- Not have received conservative treatment for shoulder rehabilitation in the last 6 months
- Having limitation of movement of the shoulder joint due to breast surgery
- Not having agreed to participate in the study
- Having undergone radical mastectomy surgery
- Having connective tissue disease
- Presence of brachial plexus paresis/plegia
- Presence of radiogenic fibrosis
- Presence of additional orthopedic (scoliosis, etc.), neurological (multiple sclerosis, stroke, etc.) and rheumatological diseases (ankylosing spondylitis, rheumatoid arthritis, etc.) that will affect upper extremity...
- Presence of active metastases
- Having undergone reconstruction surgery
- Continuation of radiotherapy (must have ended at least 3 months ago) or chemotherapy applications
- Having had a bilateral mastectomy
- To develop lymphedema in the arm-trunk
- Use of muscle relaxants
- Patients with severe chemotherapy side effects (hyperesthesia, nausea, skin changes, weakness, etc.)
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 30 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.